BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1141 related articles for article (PubMed ID: 23115326)

  • 21. [Early biomarker for AKI].
    Mori K; Mukoyama M; Nakao K
    Nihon Jinzo Gakkai Shi; 2010; 52(5):566-71. PubMed ID: 20715588
    [No Abstract]   [Full Text] [Related]  

  • 22. Biomarkers for the early detection of acute kidney injury.
    Nguyen MT; Devarajan P
    Pediatr Nephrol; 2008 Dec; 23(12):2151-7. PubMed ID: 17394022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic test for early detection of acute kidney injury.
    Hollmen M
    Expert Rev Mol Diagn; 2011 Jul; 11(6):553-5. PubMed ID: 21745008
    [No Abstract]   [Full Text] [Related]  

  • 24. [Performance neutrophil gelatinase-associated lipocalin in clinical settings].
    Gala-Bładzińska A; Kuzniewski M
    Przegl Lek; 2013; 70(6):400-3. PubMed ID: 24052978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass.
    Krawczeski CD; Goldstein SL; Woo JG; Wang Y; Piyaphanee N; Ma Q; Bennett M; Devarajan P
    J Am Coll Cardiol; 2011 Nov; 58(22):2301-9. PubMed ID: 22093507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury.
    Schinstock CA; Semret MH; Wagner SJ; Borland TM; Bryant SC; Kashani KB; Larson TS; Lieske JC
    Nephrol Dial Transplant; 2013 May; 28(5):1175-85. PubMed ID: 22529161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass.
    Prowle JR; Calzavacca P; Licari E; Ligabo EV; Echeverri JE; Bagshaw SM; Haase-Fielitz A; Haase M; Ostland V; Noiri E; Westerman M; Devarajan P; Bellomo R
    Ren Fail; 2015 Apr; 37(3):408-16. PubMed ID: 25585949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical and biological validation of a multiplex immunoassay for acute kidney injury biomarkers.
    Zhang X; Gibson B; Mori R; Snow-Lisy D; Yamaguchi Y; Campbell SC; Simmons MN; Daly TM
    Clin Chim Acta; 2013 Jan; 415():88-93. PubMed ID: 23041213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients.
    Matsa R; Ashley E; Sharma V; Walden AP; Keating L
    Crit Care; 2014 Jul; 18(4):R137. PubMed ID: 24985156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early acute kidney injury.
    Shemin D; Dworkin LD
    Crit Care Clin; 2011 Apr; 27(2):379-89. PubMed ID: 21440207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT.
    Kooiman J; van de Peppel WR; Sijpkens YW; Brulez HF; de Vries PM; Nicolaie MA; Putter H; Huisman MV; van der Kooij W; van Kooten C; Rabelink TJ
    Eur Radiol; 2015 Jul; 25(7):1926-34. PubMed ID: 25773936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time of injury affects urinary biomarker predictive values for acute kidney injury in critically ill, non-septic patients.
    de Geus HR; Fortrie G; Betjes MG; van Schaik RH; Groeneveld AB
    BMC Nephrol; 2013 Dec; 14():273. PubMed ID: 24321290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure.
    Verbrugge FH; Dupont M; Shao Z; Shrestha K; Singh D; Finucan M; Mullens W; Tang WH
    J Card Fail; 2013 Sep; 19(9):621-8. PubMed ID: 24054338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel biomarkers of acute kidney injury: time for implementation?
    Endre ZH
    Biomark Med; 2014; 8(10):1185-8. PubMed ID: 25525979
    [No Abstract]   [Full Text] [Related]  

  • 36. Pediatric reference ranges for acute kidney injury biomarkers.
    Bennett MR; Nehus E; Haffner C; Ma Q; Devarajan P
    Pediatr Nephrol; 2015 Apr; 30(4):677-85. PubMed ID: 25348707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients.
    Makris K; Markou N; Evodia E; Dimopoulou E; Drakopoulos I; Ntetsika K; Rizos D; Baltopoulos G; Haliassos A
    Clin Chem Lab Med; 2009; 47(1):79-82. PubMed ID: 19055468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New biomarkers for acute renal injury.
    Soni SS; Pophale R; Ronco C
    Clin Chem Lab Med; 2011 Aug; 49(8):1257-1263. PubMed ID: 21726165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers for the early detection of acute kidney injury.
    Devarajan P
    Curr Opin Pediatr; 2011 Apr; 23(2):194-200. PubMed ID: 21252674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical application neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 as indicators of inflammation persistence and acute kidney injury in children with urinary tract infection.
    Petrovic S; Bogavac-Stanojevic N; Peco-Antic A; Ivanisevic I; Kotur-Stevuljevic J; Paripovic D; Sopic M; Jelic-Ivanovic Z
    Biomed Res Int; 2013; 2013():947157. PubMed ID: 23936859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.